We are a medical device company, incorporated in 1987, engaged in the design,
development, sale and marketing of an implantable medical device, the VNS
Therapy� System, that provides neuromodulation therapy for the treatment of
refractory epilepsy and treatment-resistant depression (�TRD�). We are also
investigating the use of vagus nerve stimulation and other neuromodulation
therapy for other indications, including chronic heart failure, and developing
non-implantable device solutions for the management of epilepsy.